Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.

被引：0

作者：

Gürman, G ^{[1
]}

Üstün, C ^{[1
]}

Arslan, O ^{[1
]}

Beksaç, M ^{[1
]}

Konuk, N ^{[1
]}

Arat, M ^{[1
]}

Celebi, H ^{[1
]}

Özcan, M ^{[1
]}

Ilhan, O ^{[1
]}

Demirer, T ^{[1
]}

Akan, H ^{[1
]}

Uysal, A ^{[1
]}

Koc, H ^{[1
]}

机构：

[1] Ankara Univ, Sch Med, Ibni Sina Hosp, Dept Hematol, TR-06100 Ankara, Turkey

来源：

BLOOD | 1998年 / 92卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4509

引用

页码：350B / 351B

页数：2

共 50 条

[31] Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies [J].

Sorror, Mohamed L. ;

Sandmaier, Brenda M. ;

Storer, Barry E. ;

Franke, Georg N. ;

Laport, Ginna G. ;

Chauncey, Thomas R. ;

Agura, Edward ;

Maziarz, Richard T. ;

Langston, Amelia ;

Hari, Parameswaran ;

Pulsipher, Michael A. ;

Bethge, Wolfgang ;

Sahebi, Firoozeh ;

Bruno, Benedetto ;

Maris, Michael B. ;

Yeager, Andrew ;

Petersen, Finn Bo ;

Vindelov, Lars ;

McSweeney, Peter A. ;

Huebel, Kai ;

Mielcarek, Marco ;

Georges, George E. ;

Niederwieser, Dietger ;

Blume, Karl G. ;

Maloney, David G. ;

Storb, Rainer .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (17) :1874-1883

[32] Cytomegalovirus reactivation and relapse following allogeneic stem cell transplantation using a reduced intensity conditioning regimen. [J].

Rao, R ;

Chin, K ;

Chan, G ;

Sprague, K ;

Klein, A ;

Miller, KB ;

Foss, F ;

Snydman, DR .

BLOOD, 2004, 104 (11) :359B-360B

[33] Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation [J].

Nagler, A ;

Or, R ;

Naparstek, E ;

Varadi, G ;

Slavin, S .

EXPERIMENTAL HEMATOLOGY, 2000, 28 (09) :1096-1104

[34] Reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in 60 adult patients with hematological malignancies in single center experience [J].

Gil, L ;

Kozlowska-Skrzypczak, M ;

Sawinski, K ;

Gozdzik, J ;

Czyz, A ;

Hansz, J ;

Komarnicki, M .

BONE MARROW TRANSPLANTATION, 2003, 31 :S145-S145

[35] Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen. [J].

Tolar, Jakub ;

Bonfim, Carmem ;

Grewal, Satkiran ;

Orchard, Paul .

BLOOD, 2006, 108 (11) :897A-897A

[36] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Different Doses of Antithymocyte Globulin Containing Conditioning in Hematological Malignancies [J].

Gokgoz, Zafer ;

Soydan, Ender ;

Gokmen, Ayla ;

Arslan, Onder ;

Ilhan, Osman ;

Ozcan, Muhit .

BONE MARROW TRANSPLANTATION, 2018, 53 :284-285

[37] Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation [J].

Tabbara, IA ;

Ingram, RA .

EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) :559-566

[38] Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies [J].

S Masouridi-Levrat ;

A Pradier ;

F Simonetta ;

L Kaiser ;

Y Chalandon ;

E Roosnek .

Bone Marrow Transplantation, 2016, 51 :440-442

[39] Second allogeneic hematopoietic stem cell transplantation (HSCT) in patients with refractory hematological malignancies. [J].

Hosing, C ;

De Lima, M ;

Saliba, RM ;

Shahjahan, M ;

Couriel, D ;

Andersson, B ;

Giralt, S ;

Champlin, RE .

BLOOD, 2002, 100 (11) :430A-430A

[40] Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies [J].

Masouridi-Levrat, S. ;

Pradier, A. ;

Simonetta, F. ;

Kaiser, L. ;

Chalandon, Y. ;

Roosnek, E. .

BONE MARROW TRANSPLANTATION, 2016, 51 (03) :440-442

← 1 2 3 4 5 →